Menu
The Goodman Institute Health Blog
  • Home
  • Authors
    • Devon Herrick, Ph.D.
    • John C. Goodman
  • Popular Topics
    • Artificial Intelligence and Healthcare
    • Consumer-Driven Health Care
      • Affordable Care Act
      • Cost of Healthcare
      • COVID-19 and Public Health
      • Doctors & Hospitals
      • Public Insurance
      • Policy & Legislation
    • Direct Primary Care
    • Health Economics & Costs
      • Drug Prices & Regulations
      • Health Insurance
      • Health Reform
    • Medical Tourism
    • Telemedicine
    • Medicare
      • Single-Payer/Medicare-for-All
  • Goodman Institute
  • Contact
The Goodman Institute Health Blog

Category: Medicare

Friday Links

Posted on July 14, 2023July 14, 2023 by John C. Goodman
  • We have been advocating OTC birth control for years.
  • Adverse selection problems in insurance markets go away if people must insure by household rather than as individuals. At least in Pakistan.
  • Is your doctor employed by a private equity firm? (NYT)
  • AARP Represents Health Insurers, Not Seniors
  • Is compression of morbidity being reversed? Considering 300 diseases in the USA from 1990 vs. 2017, health span (health-adjusted life expectancy) grew by 2 years, but life expectancy grew by 3 years.
  • The Health Care Blog goes wacko: “The greatest health equity threat to Medicaid – and Medicare – beneficiaries is the climate crisis.”
+

How Medicare Advantage Plans Cover Drugs

Posted on July 5, 2023July 5, 2023 by John C. Goodman

Average annual deductibles in independent prescription drug plans (PDPs) are roughly four times higher than those in Medicare Advantage plans (MA-PDs) ($398 versus $90). Average monthly premiums for PDPs are also roughly 3.5 times higher than in MA-PDPs ($40 versus $11). Similarly, MA-PDP formularies cover a higher share of potentially coverable Part D drugs than PDPs (89 percent compared to 83 percent). At the same time, MA-PDPs impose utilization management requirements (such as prior authorization and quantity limits) on formulary covered drugs at a lower rate, relative to PDPs.

Source: Benedic N. Ippolito and Boris Vabson, The Impact Of Medicare Advantage Growth On Part D Competition, Costs, and Coverage. (AEI)

+

Wednesday Links

Posted on July 5, 2023July 4, 2023 by John C. Goodman
  • Judge: the federal government cannot conspire with social media to limit free speech.
  • Expanded Child tax credit: Neither labor force participation nor total hours worked changed significantly during the months when benefits were increased and work requirements were removed.
  • Study: Medicare enrollment improves financial health.
  • About 39 percent of US workers are engaged in nontraditional work (freelancing, contracting, gig, and self-employment).
+

Monday Links

Posted on July 3, 2023July 3, 2023 by John C. Goodman
  • 93% of cancer centers report a shortage of carboplatin and 70% report shortages for cisplatin.
  • Up to 500,000 U.S. cancer patients could be at risk of having their treatment disrupted. (WSJ)
  • WHO is about to declare that Aspartame, a common artificial sweetener, is “possibly carcinogenic to humans.” The back and forth on this issue never seems to end.
  • Expected lifetime out-of-pocket spending by Medicare enrollees: $157,500 (Fidelity) to $197,000 (Employee Benefit Research Institute). (NYT)
  • A single year with a grossly ineffective teacher can cost a classroom of students $1.4 million in lifetime earnings. Yet it can take 10 years and $250,000 to $450,000 to fire a lousy California teacher, and fewer than 0.002% are dismissed for unprofessional conduct or poor performance. (WSJ)
+
  • Previous
  • 1
  • …
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • …
  • 107
  • Next

For many years, our health care blog was the only free enterprise health policy blog on the internet. Then, when the NCPA closed its doors, the health blog stopped as well.

During this five-year hiatus no one else has come forward to claim the space. So, my colleagues and I have decided to restart the blog in connection with the Goodman Institute. We invite you and others to use this forum to share your views.

John C. Goodman,

Visit www.goodmaninstitute.org

Subscribe via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 40 other subscribers

Popular Topics

©2025 The Goodman Institute Health Blog | Website by Lexicom